Following Health Canada’s authorization of the AstraZeneca ChAdOx1 COVID-19 vaccine, the Honourable Anita Anand, Minister of Public Services and Procurement, announced today that Canada has secured two million doses of the AstraZeneca COVID-19 vaccine through an agreement with Verity Pharmaceuticals Canada Inc./Serum Institute of India.
AstraZeneca has licensed the manufacture of its ChAdOx1 vaccine to the Serum Institute. The first 500,000 doses will be delivered to Canada in the coming weeks and will quickly be ready for distribution to the provinces and territories. The remaining 1.5 million doses will arrive by mid-May.
The two million doses secured through this agreement are in addition to the 20 million doses already secured through an earlier agreement with AstraZeneca. Health Canada’s authorization of the AstraZeneca vaccine allows the federal government to advance its work with AstraZeneca to finalize delivery schedules for the 20 million doses.
“The Government of Canada continues to do everything possible to protect Canadians from COVID-19,” Anand said. “This includes securing a highly diverse and extensive portfolio of vaccines and taking all necessary measures to ready the country to receive them. We remain fully on track to ensure that there will be a sufficient supply so that every eligible Canadian who wants a vaccine will have access to one by the end of September.”
This announcement further supports the government’s plan to be able to provide a vaccine to everyone in Canada for whom these COVID-19 vaccines are recommended, by the end of September.
